- Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
-
Tong X, Zhi P, Lin S
- KMID: 2539475
- J Gastric Cancer.
- 2023 Jan;23(1):182-193.
- doi: 10.5230/jgc.2023.23.e12
Presently, surgery is the only treatment approach for gastric cancer and improving the prognosis of locally advanced gastric cancer is one of the key factors in promoting gastric cancer survival... -
- CITED
-
- Close
- SHARE
-
- Close
- A Big Step Forward in the New KGCA Guidelines
-
Son SY, Han SU
- KMID: 2539473
- J Gastric Cancer.
- 2023 Jan;23(1):1-2.
- doi: 10.5230/jgc.2023.23.e8
-
- CITED
-
- Close
- SHARE
-
- Close
- Role of Adjuvant Radiotherapy in Gastric Cancer
-
Yu JI
- KMID: 2539474
- J Gastric Cancer.
- 2023 Jan;23(1):194-206.
- doi: 10.5230/jgc.2023.23.e1
Although continuous improvement in the treatment outcome of localized gastric cancer has been achieved through early screening, diagnosis, and treatment and the active application of surgery and adjuvant chemotherapy, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Sentinel Node Navigation Surgery for Early Gastric Cancer
-
Booka E, Takeuchi H
- KMID: 2539477
- J Gastric Cancer.
- 2023 Jan;23(1):159-170.
- doi: 10.5230/jgc.2023.23.e4
Maintaining the postoperative quality of life (QOL) while ensuring curability without overtreatment is important in the treatment of early gastric cancer. Postoperative QOL is anticipated to be maintained through minimally... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoscopic Resection of Undifferentiated Early Gastric Cancer
-
Hirai Y, Abe S, Makiguchi ME, Sekiguchi M, Nonaka S, Suzuki H, Yoshinaga S, Saito Y
- KMID: 2539478
- J Gastric Cancer.
- 2023 Jan;23(1):146-158.
- doi: 10.5230/jgc.2023.23.e13
Endoscopic resection (ER) is widely performed for early gastric cancer (EGC) with a negligible risk of lymph node metastasis (LNM) in Eastern Asian countries. In particular, endoscopic submucosal dissection (ESD)... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Progress in Immunotherapy for Gastric Cancer
-
Yoon J, Kim TY, Oh DY
- KMID: 2539472
- J Gastric Cancer.
- 2023 Jan;23(1):207-223.
- doi: 10.5230/jgc.2023.23.e10
Gastric cancer (GC) is the fourth leading cause of cancer-related deaths worldwide. Under the standard of care, patients with advanced GC (AGC) have a median survival time of approximately 12–15... -
- CITED
-
- Close
- SHARE
-
- Close
- Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination
-
Rha SY, Chung HC
- KMID: 2539471
- J Gastric Cancer.
- 2023 Jan;23(1):224-249.
- doi: 10.5230/jgc.2023.23.e6
Gastric cancer is heterogeneous in morphology, biology, genomics, and treatment response. Alterations in human epidermal growth factor receptor 2 (HER2) overexpression, microsatellite instability (MSI) status, programmed death-ligand 1 (PD-L1) levels,... -
- CITED
-
- Close
- SHARE
-
- Close
- Mediastinal Lymph Node Dissection in Gastroesophageal Junction Adenocarcinoma
-
Kim JJ
- KMID: 2539476
- J Gastric Cancer.
- 2023 Jan;23(1):171-181.
- doi: 10.5230/jgc.2023.23.e3
Currently, the prevalence of gastroesophageal junction adenocarcinoma (GEJAC) is increasing in both Asian and Western countries, although the increasing rate in Asian countries is much slower than in Western countries.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Standardized Pathology Report for Gastric Cancer: 2nd Edition
-
Park YS, Kook MC, Kim Bh, Lee HS, Kang DW, Gu MJ, Shin OR, Choi Y, Lee W, Kim H, Song IH, Kim KM, Kim HS, Kang G, Park DY, Jin SY, Kim JM, Choi YJ, Chang HK, Ahn S, Chang MS, Han SH, Kwak Y, Seo AN, Lee SH, Cho MY, The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists
- KMID: 2539479
- J Gastric Cancer.
- 2023 Jan;23(1):107-145.
- doi: 10.5230/jgc.2023.23.e7
The first edition of ‘A Standardized Pathology Report for Gastric Cancer’ was initiated by the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists and published 17 years ago.... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
-
Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, Kim BJ, Min BH, Choi CI, Shin CM, Tae CH, Gong Cs, Kim DJ, Cho AEH, Gong EJ, Song GJ, Im HS, Ahn HS, Lim H, Kim HD, Kim JJ, Yu JI, Lee JW, Park JY, Kim JH, Song KD, Jung M, Jung MR, Son SY, Park SH, Kim SJ, Lee SH, Kim TY, Bae WK, Koom WS, Jee Y, Kim YM, Kwak Y, Park YS, Han HS, Nam SY, Kong SH, on behalf of The Development Working Group for the Korean Practice Guidelines for Gastric Cancer 2022 Task Force Team
- KMID: 2539470
- J Gastric Cancer.
- 2023 Jan;23(1):3-106.
- doi: 10.5230/jgc.2023.23.e11
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised... -
- CITED
-
- Close
- SHARE
-
- Close
